Cronos Historical Financial Ratios

CRON Stock  USD 2.13  0.05  2.40%   
Cronos is presently reporting on over 122 different financial statement accounts. To analyze all of these accounts together requires a lot of time and effort. However, using these accounts to derive some meaningful and actionable indicators such as Dividend Yield of 0.0, PTB Ratio of 0.69 or Days Sales Outstanding of 125 will help investors to properly organize and evaluate Cronos Group financial condition quickly.
  
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Cronos Group. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in persons.

About Cronos Financial Ratios Analysis

Cronos GroupFinancial ratios are relationships based on a company's financial information. They can serve as useful tools to evaluate Cronos investment potential. Financial ratio analysis can also be defined as the process of presenting financial ratios, which are mathematical indicators calculated by comparing key financial information appearing on Cronos financial statements. Financial ratios are useful tools that help investors analyze and compare relationships between different pieces of financial information across Cronos history.

Cronos Financial Ratios Chart

At this time, Cronos' Receivables Turnover is very stable compared to the past year. As of the 26th of November 2024, Graham Number is likely to grow to 4.03, while Price To Sales Ratio is likely to drop 8.66.
Add Fundamental
Price To Sales RatioDividend Yield
Ptb RatioDays Sales Outstanding
Book Value Per ShareFree Cash Flow Yield
Invested CapitalOperating Cash Flow Per Share
Average PayablesStock Based Compensation To Revenue
Capex To DepreciationPb Ratio
Ev To SalesFree Cash Flow Per Share
RoicInventory Turnover
Net Income Per ShareDays Of Inventory On Hand
Payables TurnoverSales General And Administrative To Revenue
Average InventoryResearch And Ddevelopement To Revenue
Capex To RevenueCash Per Share
PocfratioInterest Coverage
Payout RatioCapex To Operating Cash Flow
Pfcf RatioDays Payables Outstanding
Net Current Asset ValueIncome Quality
RoeTangible Asset Value
Ev To Operating Cash FlowPe Ratio
Return On Tangible AssetsEv To Free Cash Flow
Earnings YieldIntangibles To Total Assets
Net Debt To E B I T D ACurrent Ratio
Tangible Book Value Per ShareReceivables Turnover
Graham NumberShareholders Equity Per Share
Debt To EquityCapex Per Share
Graham Net NetAverage Receivables
Revenue Per ShareInterest Debt Per Share
Debt To AssetsEnterprise Value Over E B I T D A
Short Term Coverage RatiosPrice Earnings Ratio
Operating CyclePrice Book Value Ratio
Price Earnings To Growth RatioDays Of Payables Outstanding
Dividend Payout RatioPrice To Operating Cash Flows Ratio
Price To Free Cash Flows RatioPretax Profit Margin
Ebt Per EbitOperating Profit Margin
Effective Tax RateCompany Equity Multiplier
Long Term Debt To CapitalizationTotal Debt To Capitalization
Return On Capital EmployedDebt Equity Ratio
Ebit Per RevenueQuick Ratio
Dividend Paid And Capex Coverage RatioNet Income Per E B T
Cash RatioCash Conversion Cycle
Operating Cash Flow Sales RatioDays Of Inventory Outstanding
Days Of Sales OutstandingFree Cash Flow Operating Cash Flow Ratio
Cash Flow Coverage RatiosPrice To Book Ratio
Fixed Asset TurnoverCapital Expenditure Coverage Ratio
Price Cash Flow RatioEnterprise Value Multiple
Debt RatioCash Flow To Debt Ratio
Price Sales RatioReturn On Assets
Asset TurnoverNet Profit Margin
Gross Profit MarginPrice Fair Value
Return On Equity

Ptb Ratio

Price-to-Book ratio, a financial valuation metric used to compare a company's current market price to its book value. It provides insight into the value that market participants place on the company's equity relative to its net asset value.

Book Value Per Share

The ratio of equity available to common shareholders divided by the number of outstanding shares. This measure represents the value per share of a company according to its financial statements.

Average Payables

The average amount owed to suppliers and creditors over a specific period, reflecting the company's payment cycle and credit terms with suppliers.
Most ratios from Cronos' fundamentals are interrelated and interconnected. However, analyzing fundamentals ratios one by one will only give a small insight into Cronos Group current financial condition. On the other hand, looking into the entire matrix of fundamentals ratios, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Cronos Group. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in persons.
At this time, Cronos' Receivables Turnover is very stable compared to the past year. As of the 26th of November 2024, Graham Number is likely to grow to 4.03, while Price To Sales Ratio is likely to drop 8.66.
 2021 2022 2023 2024 (projected)
Days Sales Outstanding163.25124.28150.11125.03
PTB Ratio1.090.820.720.69

Cronos fundamentals Correlations

0.370.18-0.010.020.020.490.160.371.0-0.40.55-0.660.18-0.43-0.30.550.48-0.06-0.58-0.07-0.620.37-0.610.070.46
0.37-0.35-0.580.660.58-0.280.891.00.410.09-0.35-0.29-0.13-0.05-0.56-0.220.89-0.6-0.880.1-0.71-0.630.27-0.2-0.32
0.18-0.350.92-0.09-0.850.66-0.42-0.350.09-0.80.440.150.670.170.380.63-0.410.920.12-0.440.040.43-0.550.040.8
-0.01-0.580.92-0.26-0.950.71-0.65-0.58-0.09-0.750.480.320.440.180.630.67-0.660.990.34-0.440.240.54-0.590.140.65
0.020.66-0.09-0.260.34-0.160.530.660.030.17-0.580.260.110.08-0.36-0.110.34-0.24-0.44-0.03-0.21-0.760.350.3-0.24
0.020.58-0.85-0.950.34-0.660.650.580.10.75-0.45-0.32-0.34-0.11-0.61-0.610.65-0.94-0.390.37-0.29-0.530.53-0.17-0.54
0.49-0.280.660.71-0.16-0.66-0.55-0.280.44-0.770.790.030.180.020.590.99-0.40.66-0.1-0.25-0.230.67-0.940.290.62
0.160.89-0.42-0.650.530.65-0.550.890.20.2-0.58-0.24-0.080.15-0.65-0.520.9-0.66-0.740.09-0.62-0.620.56-0.31-0.39
0.371.0-0.35-0.580.660.58-0.280.890.410.09-0.35-0.29-0.13-0.05-0.56-0.220.89-0.6-0.880.1-0.71-0.630.27-0.2-0.32
1.00.410.09-0.090.030.10.440.20.41-0.340.52-0.670.09-0.45-0.320.510.53-0.15-0.61-0.03-0.650.34-0.570.060.38
-0.40.09-0.8-0.750.170.75-0.770.20.09-0.34-0.570.03-0.33-0.32-0.41-0.740.15-0.690.260.440.41-0.530.67-0.04-0.6
0.55-0.350.440.48-0.58-0.450.79-0.58-0.350.52-0.57-0.40.06-0.190.430.78-0.250.42-0.03-0.12-0.220.81-0.94-0.040.61
-0.66-0.290.150.320.26-0.320.03-0.24-0.29-0.670.03-0.4-0.130.330.610.0-0.570.350.380.070.46-0.190.230.2-0.3
0.18-0.130.670.440.11-0.340.18-0.08-0.130.09-0.330.06-0.130.08-0.20.17-0.080.50.08-0.060.080.07-0.12-0.070.82
-0.43-0.050.170.180.08-0.110.020.15-0.05-0.45-0.32-0.190.330.080.28-0.05-0.170.16-0.12-0.16-0.24-0.060.180.01-0.05
-0.3-0.560.380.63-0.36-0.610.59-0.65-0.56-0.32-0.410.430.61-0.20.280.54-0.720.60.310.010.20.48-0.490.00.1
0.55-0.220.630.67-0.11-0.610.99-0.52-0.220.51-0.740.780.00.17-0.050.54-0.350.61-0.13-0.23-0.250.64-0.940.330.6
0.480.89-0.41-0.660.340.65-0.40.90.890.530.15-0.25-0.57-0.08-0.17-0.72-0.35-0.69-0.80.11-0.71-0.40.28-0.39-0.22
-0.06-0.60.920.99-0.24-0.940.66-0.66-0.6-0.15-0.690.420.350.50.160.60.61-0.690.4-0.40.320.49-0.530.120.66
-0.58-0.880.120.34-0.44-0.39-0.1-0.74-0.88-0.610.26-0.030.380.08-0.120.31-0.13-0.80.40.010.950.240.110.240.05
-0.070.1-0.44-0.44-0.030.37-0.250.090.1-0.030.44-0.120.07-0.06-0.160.01-0.230.11-0.40.010.05-0.150.19-0.21-0.17
-0.62-0.710.040.24-0.21-0.29-0.23-0.62-0.71-0.650.41-0.220.460.08-0.240.2-0.25-0.710.320.950.05-0.020.260.23-0.07
0.37-0.630.430.54-0.76-0.530.67-0.62-0.630.34-0.530.81-0.190.07-0.060.480.64-0.40.490.24-0.15-0.02-0.750.040.55
-0.610.27-0.55-0.590.350.53-0.940.560.27-0.570.67-0.940.23-0.120.18-0.49-0.940.28-0.530.110.190.26-0.75-0.12-0.65
0.07-0.20.040.140.3-0.170.29-0.31-0.20.06-0.04-0.040.2-0.070.010.00.33-0.390.120.24-0.210.230.04-0.12-0.06
0.46-0.320.80.65-0.24-0.540.62-0.39-0.320.38-0.60.61-0.30.82-0.050.10.6-0.220.660.05-0.17-0.070.55-0.65-0.06
Click cells to compare fundamentals

Cronos Account Relationship Matchups

Cronos fundamentals Accounts

201920202021202220232024 (projected)
Price To Sales Ratio143.9151.2619.5610.239.128.66
Ptb Ratio1.951.41.090.820.720.69
Days Sales Outstanding254.1203.47163.25124.28150.11125.03
Book Value Per Share5.14.953.613.082.881.59
Free Cash Flow Yield(0.0494)(0.0743)(0.11)(0.1)(0.0581)(0.0611)
Operating Cash Flow Per Share(0.38)(0.41)(0.42)(0.24)(0.11)(0.12)
Stock Based Compensation To Revenue0.490.330.140.160.10.0955
Capex To Depreciation9.955.020.80.380.420.4
Pb Ratio1.951.41.090.820.720.69
Ev To Sales93.6928.397.771.951.481.4
Free Cash Flow Per Share(0.49)(0.52)(0.45)(0.25)(0.12)(0.13)
Roic(0.15)(0.11)0.005068(0.13)(0.0737)(0.0774)
Inventory Turnover1.091.652.82.132.472.59
Net Income Per Share7.16(0.22)(1.07)(0.46)(0.19)(0.18)
Days Of Inventory On Hand333.68221.37130.18171.5147.75155.14
Payables Turnover1.183.758.287.166.216.52
Sales General And Administrative To Revenue2.572.051.430.940.670.63
Capex To Revenue1.640.760.160.05480.03920.0373
Cash Per Share4.393.742.722.372.261.14
Pocfratio(26.29)(16.81)(9.48)(10.57)(18.57)(19.5)
Interest Coverage(97.66)(964.23)251.3(5.15)(5.92)(6.22)
Capex To Operating Cash Flow(0.3)(0.25)(0.0798)(0.0566)(0.0799)(0.0839)
Pfcf Ratio(20.23)(13.46)(8.78)(10.0)(17.2)(18.06)
Days Payables Outstanding309.6397.3344.150.9758.7755.83
Income Quality(0.11)1.890.390.530.570.29
Roe1.4(0.0436)(0.3)(0.15)(0.0673)(0.0639)
Ev To Operating Cash Flow(17.12)(9.31)(3.77)(2.01)(3.01)(3.16)
Pe Ratio1.39(32.09)(3.67)(5.57)(10.76)(10.22)
Return On Tangible Assets1.36(0.0445)(0.29)(0.14)(0.0662)(0.0629)
Ev To Free Cash Flow(13.17)(7.46)(3.49)(1.91)(2.79)(2.92)
Earnings Yield0.72(0.0312)(0.27)(0.18)(0.093)(0.0883)
Net Debt To E B I T D A(0.75)12.914.568.349.299.75
Current Ratio4.726.6319.8614.122.5423.67
Tangible Book Value Per Share4.264.233.563.012.821.44
Receivables Turnover1.441.792.242.942.432.79
Graham Number28.684.919.345.633.554.03
Shareholders Equity Per Share5.14.963.623.092.891.59

Pair Trading with Cronos

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Cronos position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Cronos will appreciate offsetting losses from the drop in the long position's value.

Moving against Cronos Stock

  0.55BMY Bristol Myers Squibb Sell-off TrendPairCorr
  0.53GILD Gilead SciencesPairCorr
  0.4EWTX Edgewise TherapeuticsPairCorr
The ability to find closely correlated positions to Cronos could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Cronos when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Cronos - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Cronos Group to buy it.
The correlation of Cronos is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Cronos moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Cronos Group moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Cronos can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching
When determining whether Cronos Group offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Cronos' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Cronos Group Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Cronos Group Stock:
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Cronos Group. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in persons.
You can also try the Portfolio Comparator module to compare the composition, asset allocations and performance of any two portfolios in your account.
Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Cronos. If investors know Cronos will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Cronos listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
0.144
Earnings Share
(0.12)
Revenue Per Share
0.267
Quarterly Revenue Growth
0.46
Return On Assets
(0.04)
The market value of Cronos Group is measured differently than its book value, which is the value of Cronos that is recorded on the company's balance sheet. Investors also form their own opinion of Cronos' value that differs from its market value or its book value, called intrinsic value, which is Cronos' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Cronos' market value can be influenced by many factors that don't directly affect Cronos' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Cronos' value and its price as these two are different measures arrived at by different means. Investors typically determine if Cronos is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Cronos' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.